Commenced first H3C Health Sciences Innovation Conference in India
The Ohio State University (OSU), public research university in the US, in association with All India Institute of Medical Sciences (AIIMS) announced commencement of first H3C Health Sciences Innovation Conference in India. The first day of the conference witnessed multi-stakeholder discussion around regenerative medicine, nanotechnology and wound care. The conference is chaired by Prof Chandan K Sen, Director, Centre for Regenerative Medicine and Cell-Based Therapies, The Ohio State University.
The Ohio State University, pioneers in regenerative medicine, will provide strong inputs for the proposed centre in the AIIMS campus, Delhi. The Indian Council for Medical Research (ICMR) and the Department of Biotechnology (DBT) will be approached for funding. The conference explored opportunities for building international collaboration networks to jointly apply for these new international funding sources through many US/India funding opportunities.
Co chaired by Prof Amit K Dinda, Professor, Department of Pathology, AIIMS, the conference witnessed participation from dignitaries like Dr Maneesh Singhal, AIIMS; and Prof Mahesh C Misra, Director, AIIMS.
The spotlight was on fostering industry relationships by inviting Indian industries for R&D partnership – from basic sciences to clinical trials. The conference also looked at opportunities in vascular biology, neuroscience, material science, regenerative medicine and cord blood banking.
Commenting on the occasion, Dr Sen said, “We are delighted to collaborate with AIIMS (India) as it offers immense opportunities for co-operation. We can learn so much from the Indian experience, given the breadth and volume of cases and specific needs. At the same time, we offer several sets of scientific expertise to enrich the new programme at AIIMS.”
“This conference will enable Ohio State faculty to meet colleagues with similar interests, discuss the latest technologies as well as share and exchange ideas for potential research collaborations, not only with academic institutions but also with biotech and pharma companies, as well as hospital and healthcare systems. It is an exciting opportunity for research engagement,” he said.
EH News Bureau
- Advertisement -